2022 News & Press Releases Applied BioCode Appoints Industry Veteran Chris Bernard as Chief Executive Officer 03/24/2022 Applied BioCode announced today that Chris Bernard has been appointed as their new Chief Executive Officer (CEO). Mr. Bernard joins … Read More
2022 News & Press Releases Applied BioCode Announces Exclusive Partner Distribution Agreement with Hardy Diagnostics, Further Broadens Reach of BioCode® MDx-3000 System into Hospitals and Reference Laboratories in the United States 03/14/2022 Hardy Diagnostics Now Offers the BioCode® MDx-3000 Exclusive U.S. Distribution of the Automated High Throughput Multiplex Molecular Diagnostic System March … Read More
2021 News & Press Releases Applied BioCode Obtains Emergency Use Authorization for CoV-2 Flu Plus Assay 12/16/2021 Applied BioCode announced today that it has received Emergency Use Authorization (EUA) from the US FDA for its BioCode® CoV-2 … Read More
2021 News & Press Releases Applied BioCode SARS-CoV-2 Test Detects Omicron and Other COVID Variants 12/06/2021 Applied BioCode announced today that it has received Emergency Use Authorization (EUA) from the US FDA for its BioCode® CoV-2 … Read More
2021 News & Press Releases Applied BioCode Launches 28 New Fungal Analyte Specific Reagents in the US 11/11/2021 Applied BioCode announced today that it has received Emergency Use Authorization (EUA) from the US FDA for its BioCode® CoV-2 … Read More
2020 News & Press Release Applied BioCode Receives Emergency Use Authorization for Pooled COVID-19 Testing 12/10/2020 SANTA FE SPRINGS, Calif.–(BUSINESS WIRE)– Applied BioCode announced today that it has received Emergency Use Authorization (EUA) from the US … Read More
2020 News & Press Release Applied BioCode SARS-CoV-2 Assay Granted Emergency Use Authorization 06/16/2020 SANTA FE SPRINGS, Calif.–(BUSINESS WIRE)– The BioCode® SARS-CoV-2 Assay is a CLIA high-complexity multiplex nucleic acid assay for the qualitative … Read More
2020 News & Press Release Applied BioCode Releases SARS-CoV-2 Assay with High Throughput BioCode® MDx-3000 System 04/23/2020 SANTA FE SPRINGS, Calif.–(BUSINESS WIRE)– The BioCode® SARS-CoV-2 Assay is a multiplex nucleic acid assay for the qualitative detection of … Read More
2020 News & Press Release Applied BioCode Receives FDA 510(k) Clearance for Syndromic Respiratory Pathogen Panel 01/06/2020 SANTA FE SPRINGS, Calif.–(BUSINESS WIRE)–Applied BioCode announced that it has received 510(k) Clearance from the U.S. Food and Drug Administration … Read More
2019 News & Press Releases Applied BioCode Submits FDA 510(k) Application for Syndromic BioCode® Respiratory Pathogen Panel 09/11/2019 SANTA FE SPRINGS, Calif.–(BUSINESS WIRE)–Applied BioCode announced today that it has submitted the BioCode® Respiratory Pathogen Panel (RPP) for use … Read More
2019 News & Press Releases Applied BioCode Obtains FDA Clearance of the Roche MagNA Pure 96 Extraction System for its Gastrointestinal Pathogen Panel 06/12/2019 Applied BioCode announced today that it has received U.S. Food and Drug Administration 510(k) clearance for the use of the … Read More
